Ovarian Cancer Clinical Trial
Study of a Rapid Triadic Communication Intention Elicitation Intervention to Improve Supportive Oncology Care Delivery
Summary
The purpose of this study is to help test an idea designed to foster more supportive talk between providers (doctors or nurse practitioners), patients, and caregivers during an outpatient oncology appointment. A caregiver is the person the patient identifies is primarily involved in their healthcare. This study is collecting your reaction to this idea in order to understand needed changes before we introduce the idea to a larger group of patients.
Full Description
This pilot study focuses on an intervention (freelisting) designed to elicit supportive oncology communication intentions among the patient-caregiver-provider triad prior to an outpatient oncology encounter. The goal is to shape communication behaviors during the encounter to improve outcomes of the encounter.
Eligibility Criteria
Inclusion Criteria:
patients will:
be adult women with an advanced, incurable gynecologic cancer (Stage III/IV disease at diagnosis combined with evidence of refractory/progressive disease after first-line treatment or recurrent disease),
be at a transition point in the illness (provider confirmed non-response to treatment, progressive disease, or a symptomatic hospitalization within the last month),
not be receiving specialty palliative care or hospice,
read/speak English, and
be able to provide written informed consent.
caregivers will:
identify as the individual who is primarily involved in the patient's care,
be able to attend the oncology encounter,
read/speak English, and
be able to provide written informed consent.
providers will:
specialize in gynecologic oncology, and
provide outpatient care at IUSCCC gynecologic oncology clinic.
Exclusion Criteria:
patients and/or caregivers will be excluded if either one or both demonstrate:
cognitive impairment, or
speech/hearing difficulties precluding participation.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Indianapolis Indiana, 46202, United States
How clear is this clinincal trial information?
